STAA 8-K: results for quarter ended Sept 26, 2025 furnished

Rhea-AI Filing Summary

STAAR Surgical Company furnished a press release reporting its financial results for the quarter ended September 26, 2025. The release is provided as Exhibit 99.1 to this report.

The information furnished under Item 2.02 is expressly stated as not being “filed” for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into Securities Act or Exchange Act filings.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000718937STAAR SURGICAL CO00007189372025-11-052025-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 5, 2025

STAAR Surgical Company

(Exact Name of Registrant as Specified in Charter)

Delaware	0-11634	95-3797439
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
25510 Commercentre Drive Lake Forest, California		92630
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626-303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common	STAA	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On November 5, 2025, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended September 26, 2025, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Press release of the Company dated November 5, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STAAR Surgical Company
November 5, 2025	By:	/s/ Stephen C. Farrell
		Stephen C. Farrell
		Chief Executive Officer

FAQ

What did STAAR Surgical (STAA) announce in this 8-K?

The company furnished a press release reporting financial results for the quarter ended September 26, 2025, attached as Exhibit 99.1.

Which item of the 8-K does this relate to for STAA?

It relates to Item 2.02, Results of Operations and Financial Condition.

When was the press release issued by STAAR Surgical?

The press release is dated November 5, 2025.

Is the furnished information deemed filed under Section 18?

No. The company states the Item 2.02 information, including Exhibit 99.1, is not deemed filed under Section 18 of the Exchange Act.

Where can investors find the detailed quarterly results for STAA?

Details are in Exhibit 99.1 to this report.

Who signed the report for STAAR Surgical?

It was signed by Stephen C. Farrell, Chief Executive Officer, on November 5, 2025.